Echo Therapeutics, Inc. Restricted Stock or Unit Expense
Echo Therapeutics, Inc. reported Restricted Stock or Unit Expense of $181.37 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2016-11-16
- Echo Therapeutics, Inc. restricted stock or unit expense for the quarter ending 2016-09-30 was $138.95K, a 768.41% increase year-over-year.
- Echo Therapeutics, Inc. restricted stock or unit expense for the quarter ending 2016-06-30 was $25.42K, a 2.22% decline year-over-year.
- Echo Therapeutics, Inc. restricted stock or unit expense for the quarter ending 2016-03-31 was $17.00K, a 19.05% decline year-over-year.
- Echo Therapeutics, Inc. restricted stock or unit expense for the quarter ending 2015-09-30 was $16.00K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month |
|---|---|---|---|
| 2016-09-30 | $138.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-16 | $164.37K derived: sum of 2 quarters · filed 2016-11-16 | $181.37K 10-Q · filed 2016-11-16 |
| 2016-06-30 | $25.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $42.42K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $17.00K 10-Q · filed 2016-05-20 | ||
| 2015-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-16 | $42.00K derived: sum of 2 quarters · filed 2016-11-16 | $42.00K 10-Q · filed 2016-11-16 |
| 2015-06-30 | $26.00K 10-Q · filed 2015-08-14 | $26.00K 10-Q · filed 2016-08-12 | |
| 2015-03-31 | $21.00K 10-Q · filed 2016-05-20 | ||
| 2014-09-30 | $349.00K 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $108.00K 10-Q · filed 2015-08-14 |